Cardinal Health Inc. will move two manufacturing facilities for radioactive agents near Ohio State University’s campus as part of a $10 million partnership for the school’s researchers to develop...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cardinal, OSU join forces on radioactive drug research
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account